Harry Mcconnell
Biographic Data
| ID | 1849397 |
|---|---|
| NAME | Harry Mcconnell |
| GIVEN NAMES | Harry |
| FAMILY NAME | Mcconnell |
| SIGNATURE | MCCONNELL H |
| AFFILIATIONS | Griffith University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The neverending trip
ObjectiveHallucinogen Persistent Perception Disorder (HPPD) is a condition where the effects of hallucinogenic drugs reoccur long after the acute effects have stopped. No established risk factors or mechanisms for HPPD have been identified. However, reports have suggested a risk phenotype for HPPD due to associations with other perceptual disturbances. With recent increases in therapeutic psychedelic drug use, it is essential to consider the exis…
Integrated Care for NDIS Participants with Complex Needs
This presentation reviews the results of five recent Australian studies we have been involved with addressing the question of health and economic outcomes and the optimal model of service for this population. Through these studies the authors propose an integrated model of care and are developing a service for roll out with the NDIS to adress these critical issues.Health professionals in hospitals are poorly prepared to work effectively with indi…
No prominent works on this page.
Integrated Care for NDIS Participants with Complex Needs
This presentation reviews the results of five recent Australian studies we have been involved with addressing the question of health and economic outcomes and the optimal model of service for this population. Through these studies the authors propose an integrated model of care and are developing a service for roll out with the NDIS to adress these critical issues.Health professionals in hospitals are poorly prepared to work effectively with indi…
The neverending trip
ObjectiveHallucinogen Persistent Perception Disorder (HPPD) is a condition where the effects of hallucinogenic drugs reoccur long after the acute effects have stopped. No established risk factors or mechanisms for HPPD have been identified. However, reports have suggested a risk phenotype for HPPD due to associations with other perceptual disturbances. With recent increases in therapeutic psychedelic drug use, it is essential to consider the exis…
Business (1 works) · Chronic Disease Management Strategies (1 works) · Cognitive psychology (1 works) · Environmental health (1 works) · Hallucinations in medical conditions (1 works) · Hallucinogen (1 works) · Health care (1 works) · Healthcare innovation and challenges (1 works) · Integrated care (1 works) · Medicine (1 works)